Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 16, 2024

BUY
$197.69 - $227.29 $1.22 Million - $1.41 Million
6,186 Added 202.36%
9,243 $2.1 Million
Q3 2023

Oct 04, 2023

BUY
$201.05 - $221.7 $68,357 - $75,378
340 Added 12.51%
3,057 $614,000
Q2 2023

Jul 19, 2023

BUY
$211.93 - $241.33 $45,353 - $51,644
214 Added 8.55%
2,717 $655,000
Q2 2022

Aug 17, 2022

BUY
$213.86 - $277.87 $21,813 - $28,342
102 Added 4.25%
2,503 $587,000
Q1 2022

May 16, 2022

SELL
$259.82 - $298.18 $42,870 - $49,199
-165 Reduced 6.43%
2,401 $633,000
Q4 2021

Feb 15, 2022

BUY
$271.6 - $314.21 $17,110 - $19,795
63 Added 2.52%
2,566 $806,000
Q3 2021

Nov 15, 2021

BUY
$274.82 - $308.34 $43,696 - $49,026
159 Added 6.78%
2,503 $704,000
Q2 2021

Aug 17, 2021

SELL
$251.87 - $278.14 $35,009 - $38,661
-139 Reduced 5.6%
2,344 $647,000
Q1 2021

May 17, 2021

BUY
$204.88 - $255.03 $45,688 - $56,871
223 Added 9.87%
2,483 $633,000
Q4 2019

Feb 13, 2020

BUY
$163.48 - $173.61 $91,548 - $97,221
560 Added 32.94%
2,260 $382,000
Q2 2019

Aug 14, 2019

SELL
$144.16 - $172.9 $1.12 Million - $1.35 Million
-7,800 Reduced 82.11%
1,700 $294,000
Q1 2019

May 15, 2019

BUY
$123.7 - $156.3 $86,590 - $109,410
700 Added 7.95%
9,500 $1.65 Million
Q4 2018

Feb 15, 2019

SELL
$120.82 - $174.09 $84,574 - $121,863
-700 Reduced 7.37%
8,800 $1.11 Million
Q3 2018

Nov 14, 2018

BUY
$167.67 - $188.27 $117,368 - $131,789
700 Added 7.95%
9,500 $1.65 Million
Q3 2017

Nov 16, 2017

BUY
$149.47 - $160.56 $1.32 Million - $1.41 Million
8,800
8,800 $1.33 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Salem Investment Counselors Inc Portfolio

Follow Salem Investment Counselors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Salem Investment Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Salem Investment Counselors Inc with notifications on news.